Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial

24 March 2023 (10:45 - 11:45)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes, cardiogenic shock and acute kidney injury Cardiogenic Shock ACVC Premium Access ESC Acute CardioVascular Care 2023 Association for Acute CardioVascular Care (ACVC)